• Je něco špatně v tomto záznamu ?

Cell cycle genes co-expression in multiple myeloma and plasma cell leukemia

Fedor Kryukov, Elena Dementyeva, Lenka Kubiczkova, Jiri Jarkovsky, Lucie Brozova, Jakub Petrik, Pavel Nemec, Sabina Sevcikova, Jiri Minarik, Zdena Stefanikova, Petr Kuglik, Roman Hajek

. 2013 ; 102 (4) : 243-249.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14064120

Grantová podpora
NT11154 MZ0 CEP - Centrální evidence projektů
NT12130 MZ0 CEP - Centrální evidence projektů
NT13190 MZ0 CEP - Centrální evidence projektů

The objective of this study was to describe co-expression correlations of cell cycle regulatory genes in multiple myeloma (MM) and plasma cell leukemia (PCL). Our results highlight the presence of dynamic equilibrium between co-expression of activator and inhibitor gene sets. Moreover inhibitor set is more sensitive to the activator changes, not vice versa. We have shown that CDKN2A expression is associated with short-term survival in newly diagnosed MM patients (survival was 30.3 ± 3.9 months for 'low' expressed and 7.5 ± 5.6 months for 'high' expressed group, p<0.0001). Moreover low-expression CDKN2A group showed time-to-progression benefit in newly diagnosed patients (remission was 20.8 ± 3.6 months for 'low' and 8.4 ± 2.7 months for 'high' expressed group, p<0.0001) as well as in whole studied cohort of MM patients (remission was 20.8 ± 2.8 months for 'low' and 9.8 ± 1.1 months for 'high' expressed group, p<0.0001). The overexpression of inhibitors can be explained as a compensatory reaction to growing "oncogenic stress".

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14064120
003      
CZ-PrNML
005      
20200219092954.0
007      
ta
008      
140704s2013 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ygeno.2013.06.007 $2 doi
035    __
$a (PubMed)23831116
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kryukov, Fedor $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Electronic address: f.kryukov@gmail.com. $7 xx0128646
245    10
$a Cell cycle genes co-expression in multiple myeloma and plasma cell leukemia / $c Fedor Kryukov, Elena Dementyeva, Lenka Kubiczkova, Jiri Jarkovsky, Lucie Brozova, Jakub Petrik, Pavel Nemec, Sabina Sevcikova, Jiri Minarik, Zdena Stefanikova, Petr Kuglik, Roman Hajek
520    9_
$a The objective of this study was to describe co-expression correlations of cell cycle regulatory genes in multiple myeloma (MM) and plasma cell leukemia (PCL). Our results highlight the presence of dynamic equilibrium between co-expression of activator and inhibitor gene sets. Moreover inhibitor set is more sensitive to the activator changes, not vice versa. We have shown that CDKN2A expression is associated with short-term survival in newly diagnosed MM patients (survival was 30.3 ± 3.9 months for 'low' expressed and 7.5 ± 5.6 months for 'high' expressed group, p<0.0001). Moreover low-expression CDKN2A group showed time-to-progression benefit in newly diagnosed patients (remission was 20.8 ± 3.6 months for 'low' and 8.4 ± 2.7 months for 'high' expressed group, p<0.0001) as well as in whole studied cohort of MM patients (remission was 20.8 ± 2.8 months for 'low' and 9.8 ± 1.1 months for 'high' expressed group, p<0.0001). The overexpression of inhibitors can be explained as a compensatory reaction to growing "oncogenic stress".
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a buněčný cyklus $x genetika $7 D002453
650    _2
$a inhibitor p16 cyklin-dependentní kinasy $x genetika $x metabolismus $7 D019941
650    _2
$a progrese nemoci $7 D018450
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a regulace genové exprese u nádorů $7 D015972
650    12
$a CDC geny $7 D018816
650    _2
$a HeLa buňky $7 D006367
650    _2
$a lidé $7 D006801
650    _2
$a plazmocelulární leukemie $x diagnóza $x genetika $7 D007952
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mnohočetný myelom $x diagnóza $x genetika $7 D009101
650    _2
$a prognóza $7 D011379
650    _2
$a analýza přežití $7 D016019
650    _2
$a časové faktory $7 D013997
650    _2
$a nádorové buňky kultivované $7 D014407
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kryukova, Elena $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0122005
700    1_
$a Bešše, Lenka $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 mub2014851432
700    1_
$a Jarkovský, Jiří $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 stk2008461294
700    1_
$a Brožová, Lucie $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0213022
700    1_
$a Petrik, Jakub $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Němec, Pavel $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0162732
700    1_
$a Ševčíková, Sabina, $d 1972- $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 mub2015859787
700    1_
$a Minarik, Jiri $u Department of Internal medicine, Faculty of Medicine and Faculty Hospital, Palacky University, Olomouc, Czech Republic
700    1_
$a Štefániková, Zdenka $u Department of Hematology and Blood Transfusion, University Hospital Bratislava, Slovak Republic $7 xx0127146
700    1_
$a Kuglík, Petr, $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Integrated Laboratory of Molecular Cytogenetics, Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic $d 1957- $7 ola2003204793
700    1_
$a Hájek, Roman, $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Clinical Hematology, University Hospital Brno, Czech Republic; Instituteof Clinical Hematology, University Hospital, Ostrava, Czech Republic $d 1964- $7 nlk20000083645
773    0_
$w MED00001912 $t Genomics $x 1089-8646 $g Roč. 102, č. 4 (2013), s. 243-249
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23831116 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140704 $b ABA008
991    __
$a 20200219093356 $b ABA008
999    __
$a ok $b bmc $g 1031604 $s 862852
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 102 $c 4 $d 243-249 $i 1089-8646 $m Genomics (San Diego, Calif.) $n Genomic $x MED00001912
GRA    __
$a NT11154 $p MZ0
GRA    __
$a NT12130 $p MZ0
GRA    __
$a NT13190 $p MZ0
LZP    __
$a Pubmed-20140704

Najít záznam

Citační ukazatele

Možnosti archivace